Join us in our new offices in Jerusalem and meet the CEOs of OurCrowd's latest investments in medical devices and cybersecurity:
CEO, HIL Applied Medical
Zack Miller, Head of Investor Community and author of Tradestream Your Way to Profits, will share insights on Building Investment Portfolios in the Age of Social Media.
This event is limited to accredited investors only. If you would like to invite colleagues, they must visit the OurCrowd website and, if they meet the criteria, click Join to register as an accredited investor.
About HIL Applied Medical
HIL developed a breakthrough cancer therapy treatment that enables hospitals to build proton therapy facilities for a fraction of the cost. This, in turn, provides patients with the otherwise costly proton therapy that can treat a greater variety of tumors than traditional methods, with 2-6 times less damage to healthy tissue. HIL’s proton therapy solution does not generate excessive radiation to the environment, vastly decreasing the need for large, reinforced facilities and making it available at a substantially lower cost while delivering superior capabilities.
Covertix provides a novel cyber-security software solution for enterprise file protection. Covertix’s patented solution has the unique ability to secure files (docs, spreadsheets, images, etc) even when they have been taken off company-controlled computers (e.g. emailed out, saved to Dropbox, or taken home on a USB stick). Competitors are only able to provide these services so long as files remain within their controlled environment; e.g. on company devices or servers on which a security solution is installed.
OurCrowd is the world's leading VC-crowdfunding platform founded by serial entrepreneur and venture capitalist Jon Medved. Based in Israel, OurCrowd enables accredited investors from around the world to access and invest in great startups at great terms. To date, OurCrowd and its members have invested over $60 million in 48 companies. Visit our website to learn more about how you can join us as an investor or entrepreneur. Read our recent press coverage in The Wall Street Journal, Forbes and Bloomberg Businessweek.